Status:
COMPLETED
Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial P05693 (P05713)
Lead Sponsor:
Organon and Co
Conditions:
Pregnancy
Neonates
Eligibility:
FEMALE
18-39 years
Brief Summary
The objective of follow-up study P05713 is to evaluate whether corifollitropin alfa (Org 36286) treatment for the induction of monofollicular growth in women who underwent ovulation induction (OI) in ...
Detailed Description
Base study P05693 (NCT00697255) was planned to include two separate stages (Ia+Ib and II). Stage Ia was open-label and uncontrolled in a small cohort of women (n=5) to explore whether the intended do...
Eligibility Criteria
Inclusion
- Participants who participated in base study P05693 (NCT00697255) and received at least one dose of corifollitropin alfa
- Ongoing pregnancy confirmed by ultrasound at least 10 weeks after bolus injection of hCG in base study P05693
- Able and willing to give written informed consent (informed consent is
- incorporated in the informed consent form of protocol P05693)
Exclusion
- None
Key Trial Info
Start Date :
May 15 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 15 2008
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT00702338
Start Date
May 15 2008
End Date
December 15 2008
Last Update
September 5 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.